← SEC 公告列表 | QXO SEC 公告 | QXO, Inc.(QXO)

重大事件 即時報告 8-K 2026-07-23

QXO提交8-K 披露為特定股東轉售逾4100萬股普通股及優先股

於 SEC 網站開啟原文

AI 繁中摘要

QXO, Inc.(代碼:QXO)於2026年7月23日向美國證交會提交8-K文件,披露已就特定賣出股東的股份轉售事宜,向證交會提交了招股說明書補充文件(Prospectus Supplement)。是次註冊涵蓋:(i) 可轉換為C系列可轉換永續優先股(Preferred Stock)的41,405,099股普通股,以及(ii) 96,267股優先股。此舉主要為履行2026年1月5日與投資者簽訂的投資協議中的註冊義務。相關法律意見(Paul, Weiss, Rifkind, Wharton & Garrison LLP出具)及同意書已一併存檔。 對投資者的潛在影響:該8-K屬於法規披露,本身不涉及營運業績或財務數據。註冊股份獲准轉售,或會增加市場流通供應量,短期可能對股價形成一定壓力,但同時亦反映公司與投資者間的協議推進順利。投資者應留意後續交易量變化及股東減持動態。
展開英文正文
false
 0001236275
 
 
 
 
 
 
 
 0001236275
 
 
 2026-07-23
 2026-07-23
 
 
 
 
 0001236275
 
 us-gaap:CommonStockMember
 
 
 
 2026-07-23
 2026-07-23
 
 
 
 
 0001236275
 
 QXO:DepositarySharesMember
 
 
 
 2026-07-23
 2026-07-23
 
 
 
 iso4217:USD
 
 
 xbrli:shares
 
 
 
 
 iso4217:USD
 
 
 xbrli:shares
 
 
 
 
 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):
July 23, 2026

 

 
 QXO,
 INC.

 
 (Exact name of registrant as specified in its charter)

 
 

 
 Delaware
  
 001-38063
  
 16-1633636

 
 (State or other jurisdiction of

 incorporation)
  
 (Commission File Number)
  
 (IRS Employer Identification No.)

 
 

 
 Five American Lane

Greenwich, Connecticut
  
 06831

 
 (Address of principal executive offices)
  
 (Zip Code)

 
 

Registrant’s telephone
number, including area code: 888-998-6000

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:

 

 
  
 ¨
 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 
 

 
  
 ¨
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 
 

 
  
 ¨
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 
 

 
  
 ¨
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

Securities registered pursuant to Section 12(b) of the Act:

 

 
 Title of each class 
  
 Trading 

Symbol(s)
  
 Name of each exchange on 

which registered

 
 Common stock, par value $0.00001 per share  
  
 QXO 
  
 New York Stock Exchange

 
 Depositary Shares, each representing a 1/20th interest in a share of 5.50% Series B Mandatory Convertible Preferred Stock, par value $0.001
per share
  
 QXO.PRB
  
 New York Stock Exchange

 
 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

  

  

 

 

Item 8.01Other Events.

 

On July 23, 2026, QXO, Inc. (the
“Company”) filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement (the
“Prospectus Supplement”) to the prospectus included in the Company’s registration statement on Form S-3ASR (File No.
333-281084), filed with the SEC on July 29, 2024 (the “Registration Statement”), covering the resale by certain selling
stockholders named therein of (i) 41,405,099 shares of the Company’s common stock (“Common Stock”) issuable upon the
conversion of shares of the Company’s Series C Convertible Perpetual Preferred Stock (“Preferred Stock”) and (ii)
96,267 shares of Preferred Stock. The Prospectus Supplement was filed by the Company in satisfaction of its obligations to register the Preferred Stock and Common Stock
pursuant to the Investment Agreement, dated as of January 5, 2026, among the Company and the investors party thereto.

 

A copy of the legal opinion of Paul, Weiss, Rifkind,
Wharton & Garrison LLP relating to the shares is filed herewith as Exhibit 5.1 and is incorporated herein by reference, and is filed
with reference to, and is hereby incorporated by reference into, the Registration Statement.

 

Item 9.01Financial Statements and Exhibits.

 

(d) Exhibits.

 

 
 Exhibit

 No.
  
 Description

 
 5.1
  
 Opinion of Paul, Weiss, Rifkind, Wharton & Garrison LLP.

 
 23.1
  
 Consent of Paul, Weiss, Rifkind, Wharton & Garrison LLP (included in Exhibit 5.1).

 
 104
  
 Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

  

  

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.

 

Date: July 23, 2026

 

 
  
 QXO, INC.

 
  
  

 
  
 By: 
 /s/ Christopher Signorello

 
  
  
 Christopher Signorello

 
  
  
 Chief Legal Officer